<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; DNA</title>
	<atom:link href="http://www.tapanray.in/tag/dna/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>A Disruptive Innovation to Fight and Cure Intractable Diseases</title>
		<link>http://www.tapanray.in/a-disruptive-innovation-to-fight-and-cure-intractable-diseases/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=a-disruptive-innovation-to-fight-and-cure-intractable-diseases</link>
		<comments>http://www.tapanray.in/a-disruptive-innovation-to-fight-and-cure-intractable-diseases/#comments</comments>
		<pubDate>Sun, 29 Oct 2017 23:44:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[encoding]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Glybera]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[intractable]]></category>
		<category><![CDATA[Kymriah]]></category>
		<category><![CDATA[Luxturna]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[Yescarta]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8483</guid>
		<description><![CDATA[Several important facets of health care often arrest general attention. These are also widely discussed, analyzed and argued vehemently &#8211; with each person or group trying to justify one’s own point of view. Among these, following 6 critical areas, broadly &#8230; <a href="http://www.tapanray.in/a-disruptive-innovation-to-fight-and-cure-intractable-diseases/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/a-disruptive-innovation-to-fight-and-cure-intractable-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Evolving Paradigm of ‘Price-Value Model’ Of Pharma Value Delivery System</title>
		<link>http://www.tapanray.in/an-evolving-paradigm-of-price-value-model-of-pharma-value-delivery-system/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=an-evolving-paradigm-of-price-value-model-of-pharma-value-delivery-system</link>
		<comments>http://www.tapanray.in/an-evolving-paradigm-of-price-value-model-of-pharma-value-delivery-system/#comments</comments>
		<pubDate>Mon, 09 May 2016 00:00:25 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[alipogene]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Ebola]]></category>
		<category><![CDATA[evolving]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Glybera]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[map]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[model]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[Price-Value]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[tiparvovec)]]></category>
		<category><![CDATA[value]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7631</guid>
		<description><![CDATA[May 4, 2016 edition of the ‘MIT Technology Review’ published an interesting article carrying the headline, “The World’s Most Expensive Medicine Is a Bust”. The obvious question that floats at the top of mind: What is this most expensive drug &#8230; <a href="http://www.tapanray.in/an-evolving-paradigm-of-price-value-model-of-pharma-value-delivery-system/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/an-evolving-paradigm-of-price-value-model-of-pharma-value-delivery-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Cure: Inching Towards The ‘Holy Grail’?</title>
		<link>http://www.tapanray.in/cancer-cure-inching-towards-the-holy-grail/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cancer-cure-inching-towards-the-holy-grail</link>
		<comments>http://www.tapanray.in/cancer-cure-inching-towards-the-holy-grail/#comments</comments>
		<pubDate>Mon, 31 Aug 2015 00:00:05 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Carter]]></category>
		<category><![CDATA[cells]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[cure]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[former]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[genome]]></category>
		<category><![CDATA[Holy-Grail]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Jimmy]]></category>
		<category><![CDATA[magic bullet]]></category>
		<category><![CDATA[Mayo Clinic]]></category>
		<category><![CDATA[normal]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[President]]></category>
		<category><![CDATA[programming]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[re-programming]]></category>
		<category><![CDATA[sequencing]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=6992</guid>
		<description><![CDATA[In a Press Conference on August 20, 2015, the 39th President of the United States, now 90-year-old  Jimmy Carter, revealed (video) that during a liver surgery earlier this month the doctors diagnosed that he has cancer. The type of cancer that he &#8230; <a href="http://www.tapanray.in/cancer-cure-inching-towards-the-holy-grail/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/cancer-cure-inching-towards-the-holy-grail/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma &amp; Healthcare: Where The Healers Turn Looters?</title>
		<link>http://www.tapanray.in/pharma-healthcare-where-the-healers-turn-looters/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-healthcare-where-the-healers-turn-looters</link>
		<comments>http://www.tapanray.in/pharma-healthcare-where-the-healers-turn-looters/#comments</comments>
		<pubDate>Mon, 24 Nov 2014 00:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[300 doctors]]></category>
		<category><![CDATA[Ahmedabad]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[clothing]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[healers]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[looters]]></category>
		<category><![CDATA[MCI]]></category>
		<category><![CDATA[memorial]]></category>
		<category><![CDATA[Nexavar]]></category>
		<category><![CDATA[NLEM]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[Octreotide]]></category>
		<category><![CDATA[Octride]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Sandostatin]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[sheep]]></category>
		<category><![CDATA[Sun]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tata]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[Wolf]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=6221</guid>
		<description><![CDATA[Two news reports of the last week, though no longer shocking, made me think exactly the same way as the headline of this article epitomizes. These reports are not just two isolated instances, but an integral part of a similar &#8230; <a href="http://www.tapanray.in/pharma-healthcare-where-the-healers-turn-looters/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-healthcare-where-the-healers-turn-looters/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>“Meeting Unmet Needs of Patients”: A New Direction</title>
		<link>http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=meeting-unmet-needs-of-patients-a-new-direction</link>
		<comments>http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/#comments</comments>
		<pubDate>Mon, 27 Jan 2014 00:00:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[banal]]></category>
		<category><![CDATA[direction]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[evergreen]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[genome]]></category>
		<category><![CDATA[genomics]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Meeting]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[personalized]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sequencing]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tufts]]></category>
		<category><![CDATA[unmet]]></category>
		<category><![CDATA[warfarin]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=4874</guid>
		<description><![CDATA[The much-hyped phrase of the global pharma majors &#8211; ‘meeting unmet needs of patients’, is very often used to create an aura around newer patented drugs of all kinds, from original to banal, including evergreen varieties such as: Evergreen Drug/Brand &#8230; <a href="http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/meeting-unmet-needs-of-patients-a-new-direction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
